3.0.0 4376 2023-03-08T19:58:02Z 2023-03-08T19:58:02Z House HR 2021-07-09 117 [Congressional Record Volume 167, Number 120 (Friday, July 9, 2021)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. ARRINGTON:H.R. 4376.Congress has the power to enact this legislation pursuantto the following:Article 1, Section 8, Clause 3[Page H3617]]]> hswm00 Ways and Means Committee House Standing hswm04 Trade Subcommittee Referred to 2021-07-09T17:31:57Z Referred to 2021-07-09T14:00:40Z 2021-07-09 hswm04 Trade Subcommittee 1 House committee actions Referred to the Subcommittee on Trade. Committee 2021-07-09 Referred to the House Committee on Ways and Means. IntroReferral H11100 2 House floor actions hswm00 Ways and Means Committee 2021-07-09 Introduced in House IntroReferral Intro-H 9 Library of Congress 2021-07-09 Introduced in House IntroReferral 1000 9 Library of Congress A000375 Rep. Arrington, Jodey C. [R-TX-19] Jodey Arrington R TX C. 19 N Foreign Trade and International Finance Foreign Trade and International Finance 00 2021-07-09 Introduced in House 2022-02-10T17:58:23Z Use Sovereignty To reduce Rx Act or the USTRx Act

This bill establishes the role of Chief Pharmaceutical Trade Negotiator within the U.S. Trade Representative (USTR) to conduct trade negotiations, enforce trade agreements relating to U.S. pharmaceutical products, and address acts, policies, or practices of high-income countries that adversely impact the market access of U.S. pharmaceutical manufacturers.

The USTR must annually compile a list of high-income countries based on official statistics of the International Bank for Reconstruction and Development of the World Bank. Based on that list, the negotiator must submit a report describing (1) such countries' actions and impacts relating to the pharmaceutical trade, and (2) the current status of any responsive actions taken by the United States.

]]> USTRx Act Official Title as Introduced To identify and take action against international trade practices of high income countries that unfairly exploit innovation by deviating from market-based policies and unfairly exploit United States innovation, and for other purposes. Introduced in House IH Display Title USTRx Act Short Title(s) as Introduced USTRx Act Introduced in House IH Short Title(s) as Introduced Use Sovereignty To reduce Rx Act Introduced in House IH Introduced in House 2021-07-09T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-117hr4376ih/xml/BILLS-117hr4376ih.xml 2021-07-09 Referred to the Subcommittee on Trade. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.